ribavirin has been researched along with Scleroderma, Localized in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamiya, K; Komine, M; Maekawa, T; Murata, S; Ohtsuki, M; Waki, Y | 1 |
| Nikolaou, A; Telakis, E | 1 |
2 other study(ies) available for ribavirin and Scleroderma, Localized
| Article | Year |
|---|---|
Localized scleroderma occurring after treatment of chronic hepatitis C with sofosbuvir and ribavirin.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Male; Middle Aged; Ribavirin; Scleroderma, Localized; Skin; Sofosbuvir; Treatment Outcome | 2019 |
Localized scleroderma (morphea) in a patient with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Scleroderma, Localized | 2009 |